James L Seward, MD | |
15830 Ballantyne Medical Pl, Suite 100, Charlotte, NC 28277-4653 | |
(704) 341-0090 | |
(704) 341-0092 |
Full Name | James L Seward |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 25 Years |
Location | 15830 Ballantyne Medical Pl, Charlotte, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326081142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 200300408 (North Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dermatology Care Of Charlotte Pa | 7911906151 | 10 |
News Archive
Comprehensive genomic profiling of cell-free DNA can provide clinically useful information in men with castration-resistant prostate cancer treated with enzalutamide, research indicates.
By 2034, nearly one-quarter of Americans will have reached retirement age, according to the United States Census Bureau. But as people age, the brain becomes more susceptible to developing disorders, such as essential tremor, Parkinson's disease, and tumors.
Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
› Verified 2 days ago
Entity Name | Dermatology Care Of Charlotte Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639195126 PECOS PAC ID: 7911906151 Enrollment ID: O20061215000251 |
News Archive
Comprehensive genomic profiling of cell-free DNA can provide clinically useful information in men with castration-resistant prostate cancer treated with enzalutamide, research indicates.
By 2034, nearly one-quarter of Americans will have reached retirement age, according to the United States Census Bureau. But as people age, the brain becomes more susceptible to developing disorders, such as essential tremor, Parkinson's disease, and tumors.
Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
James L Seward, MD 15830 Ballantyne Medical Pl, Suite 100, Charlotte, NC 28277-4653 Ph: (704) 341-0090 | James L Seward, MD 15830 Ballantyne Medical Pl, Suite 100, Charlotte, NC 28277-4653 Ph: (704) 341-0090 |
News Archive
Comprehensive genomic profiling of cell-free DNA can provide clinically useful information in men with castration-resistant prostate cancer treated with enzalutamide, research indicates.
By 2034, nearly one-quarter of Americans will have reached retirement age, according to the United States Census Bureau. But as people age, the brain becomes more susceptible to developing disorders, such as essential tremor, Parkinson's disease, and tumors.
Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.
The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
› Verified 2 days ago
Dr. Coleman Eric Altman, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2630 E Seventh St, Suite 200, Charlotte, NC 28204 Phone: 704-364-6110 Fax: 704-364-4245 | |
Sam Wu, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 309 S Sharon Amity Rd Ste 200, Charlotte, NC 28211 Phone: 704-344-8846 | |
Dr. Deborah Gardner Nixon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8936 Blakeney Professional Dr, Charlotte, NC 28277 Phone: 704-341-0090 Fax: 704-341-0092 | |
Dr. Curtis Wayne Schupbach, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2620 E 7th St, Charlotte, NC 28204 Phone: 704-358-9900 Fax: 704-344-0105 | |
Daren Diiorio, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4525 Cameron Valley Pkwy, Ste 2100, Charlotte, NC 28211 Phone: 704-355-5100 | |
Dr. Marc Alan Darst, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11301 Golf Links Dr N, Suite 203, Charlotte, NC 28277 Phone: 704-321-3376 Fax: 704-541-6558 | |
Jonathan M Olson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15830 Ballantyne Medical Pl, Suite 225, Charlotte, NC 28277 Phone: 704-919-1105 Fax: 704-910-3163 |